{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T07:15:51Z","timestamp":1758093351932,"version":"3.44.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.fertnstert.2011.02.053","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T17:28:20Z","timestamp":1301333300000},"page":"1917-1921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medical history screening for thrombophilic risk: is this adequate?"],"prefix":"10.1016","volume":"95","author":[{"given":"Waltraud","family":"Eggert-Kruse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Horlbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Strowitzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2011.02.053_bib1","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-0029-1242723","article-title":"Laboratory investigation of thrombophilia: the good, the bad, and the ugly","volume":"35","author":"Favaloro","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archinte.159.5.445","article-title":"Predictors of survival after deep vein thrombosis and pulmonary embolism","volume":"159","author":"Heit","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.10234","article-title":"The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies","volume":"92","author":"Marchiori","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199909093411104","article-title":"The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation","volume":"341","author":"De Stefano","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"Br Med J (BMJ)"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/13697137.2010.528814","article-title":"Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: implications for hormone replacement therapy","volume":"13","author":"Botto","year":"2011","journal-title":"Climacteric"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib9","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1550-8579(05)80061-0","article-title":"Postmenopausal hormone replacement therapy and venous thromboembolism","volume":"2","author":"Wu","year":"2005","journal-title":"Gend Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review","volume":"94","author":"Wu","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib12","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1161\/CIRCULATIONAHA.105.565556","article-title":"Prothrombotic mutations, hormone therapy and venous thromboembolism among postmenopausal women","volume":"112","author":"Straczek","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1521-690X(02)00079-9","article-title":"Hormone therapy and venous thromboembolism","volume":"17","author":"Peverill","year":"2003","journal-title":"Best Pract Res Clin Endocrin Metabolism"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1521-6934(03)00015-4","article-title":"Thrombophilias and gynecology","volume":"17","author":"Bloemenkamp","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib15","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/humrep\/12.10.2167","article-title":"Thromboembolic disease associated with ovarian stimulation and assisted conception techniques","volume":"12","author":"Steward","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.thromres.2009.02.006","article-title":"The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization","volume":"12","author":"Brummel-Ziedins","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2141.2001.03118.x","article-title":"Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathway","volume":"115","author":"Curvers","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1600-0897.2003.00049.x","article-title":"Inherited thrombophilia: impact on human reproduction","volume":"50","author":"Buchholz","year":"2003","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2141.2008.07444.x","article-title":"Screening and treatment for heritable thrombophilia in pregnancy failure: inconsistencies among UK early pregnancy units","volume":"144","author":"Norrie","year":"2009","journal-title":"Br J Haemotol"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib20","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/blood-2010-01-267252","article-title":"SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage","volume":"115","author":"Clark","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0037-1614519","article-title":"Activated protein C resistance (FV:Q506) and pregnancy","volume":"81","author":"Lindquist","year":"1999","journal-title":"Throm Haemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2006-931801","article-title":"Thrombophilias and recurrent pregnancy loss","volume":"24","author":"Kutteh","year":"2006","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden mutation","volume":"130","author":"Meinhardi","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0015-0282(01)02971-5","article-title":"Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage","volume":"77","author":"Sarig","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1365-2141.1992.tb08264.x","article-title":"Diagnosis of APC resistance during pregnancy","volume":"92","author":"Cumming","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib27","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1073\/pnas.91.4.1396","article-title":"Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V","volume":"91","author":"Dahlb\u00e4ck","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-0038-1653860","article-title":"Resistance to activated protein C, the Arg 506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons","volume":"73","author":"Dahlb\u00e4ck","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199402243300801","article-title":"Resistance to activated protein C as a basis for venous thrombosis","volume":"330","author":"Svensson","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0038-1657574","article-title":"Resistance to activated protein C caused by the Factor V R506Q mutation is a common risk factor for venous thrombosis","volume":"78","author":"Dahlb\u00e4ck","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2007-994931","article-title":"Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FV506Q mutations","volume":"25","author":"Dahlb\u00e4ck","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1538-7836.2003.00016.x","article-title":"The discovery of activated protein C resistance","volume":"1","author":"Dahlb\u00e4ck","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","article-title":"Venous thrombosis due to poor anticoagulant response to activated protein C. Leiden Thrombophilia Study","volume":"342","author":"Koster","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib35","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(94)92940-8","article-title":"Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis","volume":"343","author":"Z\u00f6ller","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib36","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1172\/JCI117623","article-title":"Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C","volume":"94","author":"Z\u00f6ller","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-127-10-199711150-00007","article-title":"Factor V Leiden mutation and the risk for thromboembolic disease: a clinical perspective","volume":"127","author":"Price","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000441-200108000-00007","article-title":"Factor V Leiden: a clinical review","volume":"322","author":"Lee","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","article-title":"Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens","volume":"348","author":"Jick","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen\/progestin regimen on heart disease risk factors in postmenopausal women","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib41","first-page":"607","article-title":"The risk of mortality and the factor V Leiden mutation in a population-based cohort","volume":"80","author":"Heijmans","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.0007-1048.2002.03356.x","article-title":"Hormone replacement therapy, postthrombotic mutations and the risk of VTE","volume":"116","author":"Rosendaal","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","article-title":"Case control study of venous thromboembolism risk in users of hormone replacement therapy","volume":"348","author":"Daly","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1034\/j.1600-0412.2003.00118.x","article-title":"Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women","volume":"82","author":"Lindquist","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib45","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(95)91803-5","article-title":"World distribution of factor V Leiden","volume":"346","author":"Rees","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib46","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.1997.03540400055031","article-title":"Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening","volume":"277","author":"Ridker","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0049-3848(09)70002-7","article-title":"Pathogenesis and management of antiphospholipid syndrome","volume":"123","author":"Greaves","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib48","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1182\/blood-2002-02-0343","article-title":"Functional characterization of recombinant FV Cambridge and FV Hong Kong","volume":"100","author":"Norstroem","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib49","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1182\/blood-2003-06-2092","article-title":"Functional characterization of Factor V lle359Thr: a novel mutation associated with thrombosis","volume":"103","author":"Steen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib50","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.V92.7.2599","article-title":"Clinical significance of Arg 306 of factor V gene","volume":"92","author":"Liang","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib51","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V93.4.1271","article-title":"A reduced sensitivity for activated protein C in the absence of factor V Leiden mutation increases the risk of venous thrombosis","volume":"93","author":"de Visser","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-130-8-199904200-00004","article-title":"Activated protein C resistance and Factor V Leiden mutation are independent risk factors for venous thromboembolism","volume":"130","author":"Rodeghiero","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib53","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1160\/TH03-10-0621","article-title":"Oral contraceptive use in women with anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis","volume":"91","author":"Legnani","year":"2004","journal-title":"Thromb Heamost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib54","first-page":"67","article-title":"Recommendations from the EGAPP Working Group: routine testing for factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members","volume":"13","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib55","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1055\/s-0037-1615372","article-title":"Factor V Leiden and venous thrombosis in Danish centenarians","volume":"80","author":"Kristensen","year":"1998","journal-title":"Throm Haemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib56","first-page":"1146","article-title":"Pulmonary embolism","volume":"2","author":"Jordan","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib57","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(80)91550-0","article-title":"Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content","volume":"1","author":"Bottiger","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib58","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0038-1657547","article-title":"Oral contraceptives and thrombotic disease: risk of venous thromboembolism","volume":"78","author":"Helmerhorst","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib59","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00001721-200207000-00001","article-title":"Effects of second and third generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation","volume":"13","author":"Kemmeren","year":"2002","journal-title":"Blood Coagul Fibrinol"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib60","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1055\/s-0037-1613857","article-title":"Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45\u201364 years: relationship to hormone replacement therapy","volume":"83","author":"Lowe","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjmed.2004.01.018","article-title":"Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology","volume":"117","author":"Cushman","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613145","article-title":"Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test","volume":"88","author":"Curvers","year":"2002","journal-title":"Throm Haemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib63","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.ATV.0000018301.91721.94","article-title":"Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease","volume":"22","author":"Herrington","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib64","first-page":"49","article-title":"Inherited thrombophilia and pregnancy: the obstetric perspective","volume":"24","author":"Bonnar","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib65","first-page":"1","article-title":"Hormone replacement therapy and venous thromboembolism","volume":"No. 19","year":"2004","journal-title":"Royal College of Obstetricians and Gynaecologists (RCOG) Guideline"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib66","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archinte.163.9.1105","article-title":"Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception","volume":"163","author":"Cosmi","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib67","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.thromres.2007.12.026","article-title":"Family history as a risk factor for venous thromboembolism","volume":"122","author":"Noboa","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib68","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinternmed.2008.589","article-title":"The value of family history as a risk indicator for venous thrombosis","volume":"169","author":"Bezemer","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2011.02.053_bib69","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1001\/jama.2009.853","article-title":"Predictive value of Factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation","volume":"301","author":"Segal","year":"2009","journal-title":"JAMA"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028211003621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028211003621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:51:19Z","timestamp":1758009079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028211003621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0015028211003621"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2011.02.053","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical history screening for thrombophilic risk: is this adequate?","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2011.02.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}